학술논문

A novel and de novo deletion in the OCRL1 gene associated with a severe form of Lowe syndrome
Document Type
Report
Source
International Urology and Nephrology. December 2013 45(6):1767-1771
Subject
Cataracts
Exonic deletion
Low molecular weight proteinuria
Mental retardation
Proximal tubulopathy
Language
English
ISSN
0301-1623
1573-2584
Abstract
The oculocerebrorenal syndrome of Lowe (OCRL) is an X-linked disorder. The mutation of the gene OCRL1 localized at Xq26.1, coding for the enzyme phosphatidylinositol (4,5) bisphosphate (PIP2P) 5-phosphatase, is responsible for the phenotypic characteristics of the disease. We report a 22-year-old male with a severe form of OCRL syndrome, diagnosed on the basis of congenital cataracts, severe psychomotor and cognitive deficits, and renal tubular dysfunction without Fanconi syndrome. The patient presented low molecular weight proteinuria, nephrocalcinosis, nephrolithiasis, rickets, and growth retardation and developed progressive renal failure. Genetic analysis showed a novel and de novo deletion of exons 10–13 in the OCRL1 gene.